Aug. 5, 2002
The latest developments in Ion Channel research at the discovery, preclinical, and clinical stages will be the focus of the 2nd International "Ion Channels in Drug Discovery & Development" taking place in Princeton, NJ on October 24-25, 2002, announces Strategic Research Institute.
Research over the past decade has revealed that ion channels have therapeutic potential in a number of diseases such as Parkinson's, Alzheimer's, neuropathic pain, sickle cell disease, and many others. The meeting will cover topics such as automated electrophysiology, emerging targets & pharmacology, and preclinical & clinical development of Ion Channel compounds, with pharmaceutical, biotech, and academic scientists revealing their newest findings.
Highlights of the meeting include:
To receive the full agenda and/or register for the conference, please contact Jon E. Liong of Strategic Research Institute 212-967-0095, x243 (please include name, corporate affiliation, mailing address, and fax number).
Strategic Research Institute
Web Site: http://www.srinstitute.com
Copyright © 1996-2002 PR Newswire Association LLC